A Ubiquitous Chronic Disease Care system using cellular phones and the internet

Hye-Jin Yoo, M. S. Park, T. N. Kim, S. J. Yang, Geum-Joon Cho, T. G. Hwang, Sei-Hyun Baik, D. S. Choi, Gil-Hong Park, Kyung Mook Choi

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Aims The rapidly increasing prevalence of chronic diseases is an important challenge to healthcare systems worldwide. To improve the quality and efficiency of chronic disease care, we investigated the effectiveness and applicability of the Ubiquitous Chronic Disease Care (UCDC) system using cellular phones and the internet for overweight patients with both Type 2 diabetes and hypertension. Methods We conducted a randomized, controlled clinical trial over 3 months that included 123 patients at a university hospital and a community public health centre. Results After 12 weeks, there were significant improvements in HbA 1c in the intervention group (7.6 ± 0.9% to 7.1 ± 0.8%, P < 0.001) compared with the control group (7.4 ± 0.9% to 7.6 ± 1.0%, P = 0.03). Furthermore, we observed a significant reduction in systolic and diastolic blood pressure, as well as improvements in total cholesterol, low-density lipoprotein-cholesterol and triglyceride levels in the intervention group. Furthermore, there was a significant increase in adiponectin levels in the intervention group compared with the control group, although high-sensitivity C-reactive protein and interleukin-6 levels did not change in either group. Conclusions The novel UCDC system presented in this paper improved multiple metabolic parameters simultaneously in overweight patients with both Type 2 diabetes and hypertension.

Original languageEnglish
Pages (from-to)628-635
Number of pages8
JournalDiabetic Medicine
Volume26
Issue number6
DOIs
Publication statusPublished - 2009 Jun 1

Fingerprint

Cell Phones
Internet
Chronic Disease
Type 2 Diabetes Mellitus
Blood Pressure
Hypertension
Community Health Centers
Control Groups
Adiponectin
C-Reactive Protein
LDL Cholesterol
Interleukin-6
Randomized Controlled Trials
Public Health
Cholesterol
Delivery of Health Care

Keywords

  • Chronic disease
  • Diabetes
  • Hypertension
  • Internet
  • Obesity

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A Ubiquitous Chronic Disease Care system using cellular phones and the internet. / Yoo, Hye-Jin; Park, M. S.; Kim, T. N.; Yang, S. J.; Cho, Geum-Joon; Hwang, T. G.; Baik, Sei-Hyun; Choi, D. S.; Park, Gil-Hong; Choi, Kyung Mook.

In: Diabetic Medicine, Vol. 26, No. 6, 01.06.2009, p. 628-635.

Research output: Contribution to journalArticle

@article{bf58e04d558e49baa6ffafbdfcd46a5c,
title = "A Ubiquitous Chronic Disease Care system using cellular phones and the internet",
abstract = "Aims The rapidly increasing prevalence of chronic diseases is an important challenge to healthcare systems worldwide. To improve the quality and efficiency of chronic disease care, we investigated the effectiveness and applicability of the Ubiquitous Chronic Disease Care (UCDC) system using cellular phones and the internet for overweight patients with both Type 2 diabetes and hypertension. Methods We conducted a randomized, controlled clinical trial over 3 months that included 123 patients at a university hospital and a community public health centre. Results After 12 weeks, there were significant improvements in HbA 1c in the intervention group (7.6 ± 0.9{\%} to 7.1 ± 0.8{\%}, P < 0.001) compared with the control group (7.4 ± 0.9{\%} to 7.6 ± 1.0{\%}, P = 0.03). Furthermore, we observed a significant reduction in systolic and diastolic blood pressure, as well as improvements in total cholesterol, low-density lipoprotein-cholesterol and triglyceride levels in the intervention group. Furthermore, there was a significant increase in adiponectin levels in the intervention group compared with the control group, although high-sensitivity C-reactive protein and interleukin-6 levels did not change in either group. Conclusions The novel UCDC system presented in this paper improved multiple metabolic parameters simultaneously in overweight patients with both Type 2 diabetes and hypertension.",
keywords = "Chronic disease, Diabetes, Hypertension, Internet, Obesity",
author = "Hye-Jin Yoo and Park, {M. S.} and Kim, {T. N.} and Yang, {S. J.} and Geum-Joon Cho and Hwang, {T. G.} and Sei-Hyun Baik and Choi, {D. S.} and Gil-Hong Park and Choi, {Kyung Mook}",
year = "2009",
month = "6",
day = "1",
doi = "10.1111/j.1464-5491.2009.02732.x",
language = "English",
volume = "26",
pages = "628--635",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - A Ubiquitous Chronic Disease Care system using cellular phones and the internet

AU - Yoo, Hye-Jin

AU - Park, M. S.

AU - Kim, T. N.

AU - Yang, S. J.

AU - Cho, Geum-Joon

AU - Hwang, T. G.

AU - Baik, Sei-Hyun

AU - Choi, D. S.

AU - Park, Gil-Hong

AU - Choi, Kyung Mook

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Aims The rapidly increasing prevalence of chronic diseases is an important challenge to healthcare systems worldwide. To improve the quality and efficiency of chronic disease care, we investigated the effectiveness and applicability of the Ubiquitous Chronic Disease Care (UCDC) system using cellular phones and the internet for overweight patients with both Type 2 diabetes and hypertension. Methods We conducted a randomized, controlled clinical trial over 3 months that included 123 patients at a university hospital and a community public health centre. Results After 12 weeks, there were significant improvements in HbA 1c in the intervention group (7.6 ± 0.9% to 7.1 ± 0.8%, P < 0.001) compared with the control group (7.4 ± 0.9% to 7.6 ± 1.0%, P = 0.03). Furthermore, we observed a significant reduction in systolic and diastolic blood pressure, as well as improvements in total cholesterol, low-density lipoprotein-cholesterol and triglyceride levels in the intervention group. Furthermore, there was a significant increase in adiponectin levels in the intervention group compared with the control group, although high-sensitivity C-reactive protein and interleukin-6 levels did not change in either group. Conclusions The novel UCDC system presented in this paper improved multiple metabolic parameters simultaneously in overweight patients with both Type 2 diabetes and hypertension.

AB - Aims The rapidly increasing prevalence of chronic diseases is an important challenge to healthcare systems worldwide. To improve the quality and efficiency of chronic disease care, we investigated the effectiveness and applicability of the Ubiquitous Chronic Disease Care (UCDC) system using cellular phones and the internet for overweight patients with both Type 2 diabetes and hypertension. Methods We conducted a randomized, controlled clinical trial over 3 months that included 123 patients at a university hospital and a community public health centre. Results After 12 weeks, there were significant improvements in HbA 1c in the intervention group (7.6 ± 0.9% to 7.1 ± 0.8%, P < 0.001) compared with the control group (7.4 ± 0.9% to 7.6 ± 1.0%, P = 0.03). Furthermore, we observed a significant reduction in systolic and diastolic blood pressure, as well as improvements in total cholesterol, low-density lipoprotein-cholesterol and triglyceride levels in the intervention group. Furthermore, there was a significant increase in adiponectin levels in the intervention group compared with the control group, although high-sensitivity C-reactive protein and interleukin-6 levels did not change in either group. Conclusions The novel UCDC system presented in this paper improved multiple metabolic parameters simultaneously in overweight patients with both Type 2 diabetes and hypertension.

KW - Chronic disease

KW - Diabetes

KW - Hypertension

KW - Internet

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=66449124182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449124182&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2009.02732.x

DO - 10.1111/j.1464-5491.2009.02732.x

M3 - Article

C2 - 19538239

AN - SCOPUS:66449124182

VL - 26

SP - 628

EP - 635

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 6

ER -